AMD Risk Reduction

Genetic testing can provide early detection of macular degeneration, and possibly save patients’ vision | February 2011

A FEW YEARS AGO, Gary Hermsdorf learned he was in the early stages of age-related macular degeneration. A leading cause of blindness for those 55 and older that affects more than 10 million Americans, macular degeneration is caused by deterioration of the central portion of the retina, known as the macula, and characterized by loss of central vision, according to the American Macular Degeneration Foundation.

                                                                                                                                 Click Here to Read More                                                                                                                          

Studies on the singlet oxygen scavenging mechanism of human macular pigment | October 2010

Macular pigment (MP) was first described as a ‘‘yellow spot” centered on the fovea of the human eye in the 18th century, and it was classified spectroscopically as a xanthophyll carotenoid by Wald in 1945 [1], but it was not until 1985 that Bone and Landrum chemically identified that the macular pigment is a mixture of the carotenoids lutein and zeaxanthin [2]. Macular pigment is diffusely found in the peripheral retina, but it is highly concentrated (100- fold) in the foveal region of the macula, often exceeding a peak value of 1 mM in many humans [3–7]. In addition to spatial specificity, there is also remarkable chemical specificity of uptake into the human macula. Despite over a dozen readily detectable carotenoids found in human serum, only lutein, zeaxanthin, and their metabolites are found in the retina. In the fovea, the ratio of (3R,30R,60R)-lutein to (3R,30R)-zeaxanthin to (3R,30S-meso)-zeaxanthin is 1:1:1, while in the peripheral retina, lutein predominates over the zeaxanthins by a 3:1:0 ratio [1,6,8].

                                                                                                                                 Click Here to Read More                                                                                                                          

Macular Pigment Optical Density in an Aging Irish Population: the Irish Longitudinal Study on Ageing | 2010

PURPOSE:The 3 carotenoids lutein, zeaxanthin, and meso - zeaxanthin, which account for the ‘yellow spot’ at the macula and which are referred to as macular pigment (MP), are believed to play a role in visual function and protect against age-related macular degeneration (AMD) via their optical and antioxidant properties. This study was undertaken to compare MP optical density (MPOD) in a population aged 1 50 years with MPOD values from a normative database of subjects aged 18–60 years.

                                                                                                                                 Click Here to Read More                                                                                                                          

Dietary Antioxidants and the Long-term Incidence of Age-Related Macular Degeneration | Januray 2010

PURPOSE: To assess the relationship between baseline dietary and supplement intakes of antioxidants and
the long-term risk of incident age-related macular degeneration (AMD).

                                                                                                                                 Click Here to Read More                                                                                                                          

Introduction to genetic epidemiology | Januray 2010

Why should a practicing optometrist be interested in genetic epidemiology? Its very name, a combination of 2 disciplines, suggests a narrow academic niche with no obvious relevance for day-to-day work. The importance of the subject is reflected by the regularity with which genetic epidemiologic stories make headlines. Stories abound about the latest gene to be discovered that increases the risk of a disease, or that ‘‘causes’’ a trait like criminal tendency.

                                                                                                                                 Click Here to Read More                                                                                                                          

Macular Pigment Optical Density in an Aging Irish Population: the Irish Longitudinal Study on Ageing | 2010

PURPOSE:The 3 carotenoids lutein, zeaxanthin, and meso - zeaxanthin, which account for the ‘yellow spot’ at the macula and which are referred to as macular pigment (MP), are believed to play a role in visual function and protect against age-related macular degeneration (AMD) via their optical and antioxidant properties. This study was undertaken to compare MP optical density (MPOD) in a population aged 1 50 years with MPOD values from a normative database of subjects aged 18–60 years.

                                                                                                                                 Click Here to Read More                                                                                                                          

Sunlight Exposure, Antioxidants, and Age-Related Macular Degeneration | October 2008

OBJECTIVE: To examine the association of sunlight exposure and antioxidant level with age-related macular degeneration (AMD).

                                                                                                                                 Click Here to Read More                                                                                                                          

The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake With Age-Related Macular Degeneration in a Case-Control Study | September 2007

OBJECTIVE:To evaluate the relationship of dietary carotenoids, vitamin A, alpha-tocopherol, and vitamin C with prevalent age-related macular degeneration (AMD) in the Age-Related Eye Disease Study (AREDS).

                                                                                                                                 Click Here to Read More                                                                                                                          

Plasma Lutein and Zeaxanthin and Other Carotenoids as Modifiable Risk Factors for Age-Related Maculopathy and Cataract: The POLA Study | June 2006

PURPOSE: To assess the associations of plasma lutein and zeaxanthin and other carotenoids with the risk of age-related maculopathy (ARM) and cataract in the population-based Pathologies Oculaires Lie´es a` l’Age (POLA) Study.

                                                                                                                                 Click Here to Read More                                                                                                                          

LANDMARK RESEARCH SHOWS LUTEIN SUPPLEMENTATION MAY REVERSE SYMPTOMS OF MACULAR DEGENERATION | April 2004

Nutritional antioxidant supplement lutein may be an effective approach in improving symptoms of age-related macular degeneration (AMD), the leading cause of vision loss among older Americans. The LAST study (Lutein Antioxidant Supplementation Trial) is the first trial to record actual improvement in several key visual functions among patients with AMD. The data appears in this week’s Optometry – The Journal of the American Optometric Association.

                                                                                                                                 Click Here to Read More                                                                                                                          

Lutein and Zeaxanthin Status and Risk of Age-Related Macular Degeneration | June 2003

PURPOSE:To investigate the relation between plasma concentrations of lutein and zeaxanthin and age-related macular degeneration in a group of elderly men and women.

                                                                                                                                 Click Here to Read More                                                                                                                          

Contact

Reach customer service for general questions and comments.

Contact Us

Social

Twitter Facebook